Skip to content

Clinical trials

Inflammation trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Russia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20105
20111
20125
20132
20172
20181
20192
20201
20214
20223
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status4
Terminated3
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Amgen4
Boston Medical Center4
I.M. Sechenov First Moscow State Medical University3
Institute for Atherosclerosis Research, Russia3
S.LAB (SOLOWAYS)3
Federal State Budgetary Scientific Institution2
Janssen Research & Development, LLC2
Tomsk National Research Medical Center of the Russian Academy of Sciences2
Atlas Biomed1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation35
Arthritis, Rheumatoid6
Arthritis4
Arthritis, Psoriatic4
HIV Infections4
Psoriasis4
Skin Diseases4
Atherosclerosis3
Hypertension3
Obesity3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.